TY - JOUR T1 - Role of IL-33/ST2 axis in systemic inflammation of allergic airway disease JF - European Respiratory Journal JO - Eur Respir J VL - 44 IS - Suppl 58 SP - P3876 AU - Lavinia Vocca AU - Angelo Sala AU - Sebastiano Gangemi AU - Caterina Di Sano AU - Loredana Riccobono AU - Caren Uasuf AU - Giulia Anzalone AU - Anna Bonanno AU - Rosalia Paola Gagliardo AU - Mirella Profita Y1 - 2014/09/01 UR - http://erj.ersjournals.com/content/44/Suppl_58/P3876.abstract N2 - Introduction: T helper 2 (Th2) lymphocytes play an important role in chronic inflammatory process of allergic disease. IL-33 targeting ST2 receptor selectively expressed on Th2 cells surface, regulates the production of cytokines as IL-17A and IL-31.Aim: To evaluate the role of IL-33/ST2 axis in the IL-31 and IL-17 production during systemic inflammation of patients with allergic rhinitis (AR) and concomitant allergic asthma and rhinitis (AAR) compared to healthy control subjects (HC).Methods: 20 HC, 14 AR and 17 AAR subjects were recruited and blood samples collected. IL-31, IL-33, and IL-17A plasma concentrations were measured by commercial ELISA. IL-17A and IL-31 production, and ST2 receptor expression were evaluated by flow-cytometric analysis in PBMC from HC, AR, AAR (n=6 for each group). Finally, the in vitro activity of Beclomethasone Dipropionate (BDP) (10−8M to 10−7M) was evaluated on IL-17A and IL-31 production, together with ST2 receptor expression in PBMC from AAR (n=6).Results: IL-17A, IL-31 and IL-33 plasma levels were significantly higher in patients with AR and AAR than in HC. IL-31 and IL-17A intracellular levels significantly increased in PBMC from AR and AAR compared to HC while ST2 receptor expression was significantly lower. Finally, IL-17A and IL-31 intracellular levels were decreased by BDP treatment, while ST2 receptor expression increased in cultured PBMCs from AAR.Conclusions: IL-33/ST2 axis activation is a biomarker of Th2/IL-31 and Th17 immune response in the allergic airway disease. Finally, a potential therapeutic approach by BDP might be useful treatment to control Th2/IL-31 and Th17 immune response, in patients with concomitant allergic asthma and rhinitis. ER -